-+ 0.00%
-+ 0.00%
-+ 0.00%

Agenus Inc. and FDA Align on Phase 3 Registrational Trial for BOT/BAL, Moving Toward Expedited Approval Pathways

Reuters·07/07/2025 12:55:16

Please log in to view news